Related Experiment Videos
Prognostic factors for survival in soft tissue sarcoma.
J N el-Jabbour1, S S Akhtar, G R Kerr
1Department of Pathology, University of Edinburgh, UK.
British Journal of Cancer
|November 1, 1990
Summary
Prognostic factors significantly impact soft tissue sarcoma (STS) survival. Surgery, radiotherapy, and tumor characteristics like necrosis and mitotic activity are key independent predictors of patient outcomes in STS.
Area of Science:
- Oncology
- Surgical Pathology
Background:
- Soft tissue sarcomas (STS) are rare malignancies with variable prognoses.
- Identifying accurate prognostic factors is crucial for effective treatment planning and patient management.
Purpose of the Study:
- To analyze prognostic factors influencing survival in soft tissue sarcomas (STS).
- To identify independent predictors of outcome using univariate and multivariate analyses.
Main Methods:
- Retrospective analysis of 100 histologically confirmed soft tissue sarcoma (STS) cases diagnosed between 1975 and 1984.
- Univariate and multivariate proportional hazard regression models were employed to assess prognostic variables.
Main Results:
- Overall 5-year survival was 21.5%.
- Significant prognostic factors identified included extent of surgery, radiotherapy, presenting symptoms, metastases, site, histology, mitotic activity, grade, and UICC stage.
- Independent predictors varied by analysis type and tumor characteristics, with radiotherapy, surgery, necrosis, sex, and mitoses being significant in the full model.
Conclusions:
- Treatment modalities (surgery, radiotherapy) and tumor characteristics (histology, mitotic activity, necrosis, cellularity, size) are critical independent prognostic variables in soft tissue sarcomas (STS).
- Prognostic factor significance differs between superficial and deep STS, highlighting the need for tailored treatment strategies.